BCC022

Who Can Participate in the Study?

Age Group
Both

Study Details

Full Title
BCC022: Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Principal Investigator
Headshot of Jessica Muller Sun
Associate Professor of Pediatrics
Protocol Number
IRB: PRO00118933
NCT: NCT06540963
Phase
Phase II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL